| Financial Year |
March 31 2023 |
| Monetary Funds |
2,033,698,600.37 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,618,851.25 |
| Accounts Receivable |
315,029,858.25 |
| Advances to Suppliers |
2,121,171,895.02 |
| Other Receivables |
77,892,030.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,817,179,080.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
123,434,870.95 |
| Total Current Assets |
7,493,025,186.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
244,016,670.84 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,765,157.51 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
21,312,354.73 |
| Deferred Income Tax Assets |
121,648,089.24 |
| Other Non-Current Assets |
6,643,505.95 |
| Sub-Total of Non-Current Assets |
546,842,953.04 |
| Total Assets |
8,039,868,139.71 |
| Short-Term Loans |
1,328,534,869.60 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,205,965,306.54 |
| Accounts Payable |
44,074,070.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
115,331,198.32 |
| Taxes Payable |
88,490,718.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
257,037,989.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,647,710.27 |
| Other Current Liabilities |
15,310,985.09 |
| Sub-Total of Current Liabilities |
4,144,579,423.04 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
602,657.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
66,746,248.97 |
| Total Liabilities |
4,211,325,672.01 |
| Paid-In Capital(Or Share Stock) |
416,798,400.00 |
| Capital Surplus |
857,214,871.48 |
| Surplus Reserve |
176,836,253.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,291,870,132.73 |
| Minority Stockholder's Interest |
87,502,799.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,741,039,667.79 |
| Owner's Equity（Stockholder's Equity） |
3,828,542,467.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,039,868,139.71 |
